Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Paysafe
PSFE
$385M
| $2.63M | ﹤0.01% |
167,496
+89,685
| +115% | +$1.63M |
|
2527
Granite Ridge Resources
GRNT
$615M
| $2.62M | ﹤0.01% |
431,650
-11,291
| -3% | -$69.9K |
|
|
AMPS
2528
DELISTED
Altus Power
AMPS
| $2.62M | ﹤0.01% |
529,942
-4,388
| -0.8% | -$19.9K |
|
2529
Regenxbio
RGNX
$722M
| $2.62M | ﹤0.01% |
366,549
+16,819
| +5% | +$125K |
|
|
VERV
2530
DELISTED
Verve Therapeutics
VERV
| $2.6M | ﹤0.01% |
568,184
-2,534
| -0.4% | -$17K |
|
2531
IHS Holding
IHS
$2.77B
| $2.6M | ﹤0.01% |
+497,275
| New | +$1.91M |
|
2532
Theravance Biopharma
TBPH
$877M
| $2.57M | ﹤0.01% |
287,716
-6,220
| -2% | -$57.9K |
|
2533
Mercer International
MERC
$45.2M
| $2.57M | ﹤0.01% |
417,326
-210,473
| -34% | -$1.41M |
|
2534
Regional Management Corp
RM
$305M
| $2.57M | ﹤0.01% |
85,220
+34,861
| +69% | +$1.17M |
|
|
ARIS
2535
DELISTED
Aris Water Solutions
ARIS
| $2.55M | ﹤0.01% |
79,589
+642
| +0.8% | +$18.2K |
|
2536
Franklin Covey
FC
$242M
| $2.54M | ﹤0.01% |
91,821
-871
| -0.9% | -$28.8K |
|
2537
Kura Sushi USA
KRUS
$590M
| $2.53M | ﹤0.01% |
49,457
+1,313
| +3% | +$92.7K |
|
|
BKV
2538
BKV Corp
BKV
$2.63B
| $2.53M | ﹤0.01% |
120,431
-3,150
| -3% | -$71.2K |
|
2539
Global E Online
GLBE
$6.89B
| $2.51M | ﹤0.01% |
70,324
-2,708
| -4% | -$133K |
|
2540
Pacific Biosciences
PACB
$363M
| $2.5M | ﹤0.01% |
2,121,524
-54,728
| -3% | -$84K |
|
2541
Nokia
NOK
$52.6B
| $2.47M | ﹤0.01% |
468,939
+74,072
| +19% | +$362K |
|
2542
Frontier Group Holdings
ULCC
$1.75B
| $2.47M | ﹤0.01% |
568,824
-2,956
| -0.5% | -$22K |
|
2543
Global Industrial
GIC
$1.51B
| $2.47M | ﹤0.01% |
110,093
-6,925
| -6% | -$165K |
|
2544
Cerus
CERS
$468M
| $2.47M | ﹤0.01% |
1,774,137
+107,771
| +6% | +$180K |
|
2545
Keros Therapeutics
KROS
$211M
| $2.47M | ﹤0.01% |
241,923
-37,759
| -14% | -$438K |
|
2546
Aveanna Healthcare
AVAH
$2.03B
| $2.46M | ﹤0.01% |
454,619
-12,087
| -3% | -$57K |
|
2547
Village Super Market
VLGEA
$640M
| $2.45M | ﹤0.01% |
64,540
+40,609
| +170% | +$1.35M |
|
|
NXDR
2548
Nextdoor Holdings
NXDR
$983M
| $2.45M | ﹤0.01% |
1,603,161
-30,208
| -2% | -$67.5K |
|
2549
InterContinental Hotels
IHG
$23.5B
| $2.45M | ﹤0.01% |
22,347
+676
| +3% | +$84.1K |
|
2550
Build-A-Bear
BBW
$435M
| $2.45M | ﹤0.01% |
65,815
+19,743
| +43% | +$785K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.